HomeACAD • NASDAQ
ACADIA Pharmaceuticals Inc
$18.26
Mar 28, 1:21:35 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$18.20
Day range
$18.05 - $18.42
Year range
$17.56 - $33.99
Market cap
3.01B USD
Avg Volume
2.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
231.04M69.27%
Operating expense
111.46M6.77%
Net income
45.80M209.76%
Net profit margin
19.82164.83%
Earnings per share
0.28207.69%
EBITDA
36.58M180.27%
Effective tax rate
-15.35%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
438.86M5.29%
Total assets
748.96M27.41%
Total liabilities
317.20M69.27%
Total equity
431.76M
Shares outstanding
164.77M
Price to book
6.95
Return on assets
12.65%
Return on capital
19.24%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
45.80M209.76%
Cash from operations
85.39M457.97%
Cash from investing
-347.00K98.04%
Cash from financing
5.43M236.68%
Net change in cash
90.46M326.18%
Free cash flow
61.77M659.41%
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Website
Employees
598
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu